PNC Financial Services Group
RVLP

PNC Financial Services Group’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

PNC Financial Services Group’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-700
Closed -$1K – 4669
2022
Q2 		$1K Hold
700
– – ﹤0.01% 4401
2022
Q1 		$1K Hold
700
– – ﹤0.01% 4432
2021
Q4 		$1K Hold
700
– – ﹤0.01% 4357
2021
Q3 		$2K Hold
700
– – ﹤0.01% 4158
2021
Q2 		$2K Hold
700
– – ﹤0.01% 4070
2021
Q1 		$2K Hold
700
– – ﹤0.01% 3985
2020
Q4 		$3K Hold
700
– – ﹤0.01% 3810
2020
Q3 		$4K Buy
+700
New +$4.03K ﹤0.01% 3735

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group's RVLP Position: Q3 2022 in Review

PNC Financial Services Group sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2022, closing a stake of 700 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in RVLP in Q3 2020 and held it in 8 quarters. The position peaked at $4K in Q3 2020. 46 funds tracked by Wall St. Rank hold RVLP as of Q3 2022.

  • PNC Financial Services Group reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 700 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2022, an estimated $1K.
  • PNC Financial Services Group first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q3 2020 and held it in 8 quarters.
  • PNC Financial Services Group's RVL Pharmaceuticals plc Ordinary Shares position peaked at $4K in Q3 2020.
  • 46 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2022.

Based on PNC Financial Services Group's 13F filing for Q3 2022, filed 10 Nov 2022.